Quantcast
Last updated on April 23, 2014 at 11:05 EDT

Latest Aplastic Anemia & MDS International Foundation Stories

2012-06-13 02:26:59

ROCKVILLE, Md., June 13, 2012 /PRNewswire/ -- This week's announcement by ABC News' Robin Roberts that she has been diagnosed with MDS (myelodysplastic syndrome) has drawn national attention to this bone marrow failure disorder. Since 1983, the Aplastic Anemia & MDS International Foundation (www.AAMDS.org) has provided education and support to patients with MDS. MDS is a group of rare disorders affecting the bone marrow. People with MDS have an abnormal number of red and white blood...

2011-12-06 10:00:00

<font size="2" face="Arial"> </font> <font size="2" face="Arial">ROCKVILLE, Md.</font>, Dec. 6, 2011 /PRNewswire/ -- The Aplastic Anemia & MDS International Foundation (AA&MDSIF) is pleased to announce the launch of the Treating MDS Toolkit, a new, free resource developed for health care providers to communicate with and support their patients with myelodysplastic syndromes (MDS). The toolkit was developed in response to the results of an MDS patient...

2008-08-21 12:01:28

The Aplastic Anemia & MDS International Foundation (AA&MDSIF) is pleased to inform patients that the U.S. Food & Drug Administration (FDA) has expanded the label for VIDAZA (azacitidine) to include data from the AZA-001 trial, which found that Vidaza is the only agent that extends survival in MDS (myelodysplastic syndromes) patients. Vidaza was also shown to delay progression to acute myelogenous leukemia (AML) in patients with MDS. Roughly 30 percent of patients diagnosed with...